SonderMind
PrivateLast Round
Series C
Jul 27, 2021
Est. Valuation
$1.1B
Total Funding Raised
$274.5M
Company Overview
SonderMind operates in Healthcare & Life Sciences and is based in Denver, Colorado. Its latest recorded funding round was a Series C round in July 2021.
SonderMind is a healthtech company that provides an integrated mental health platform connecting individuals with licensed therapists and psychiatry providers through insurance-covered, personalized care.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Medical AI
Business Model
B2B2C
Customer Profile
Marketplace Commission, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SonderMind Comparables
Compare SonderMind with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rula | 86% | |
| Two Chairs | 84% | |
| Grow Therapy | 83% |
For institutional investors. Book with your work email.
SonderMind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 27, 2021 | ||||
| Series B | Apr 5, 2020 | ||||
| Series A | Apr 23, 2019 | ||||
| Seed | May 30, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SonderMind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Service Provider Capital | Seed |
| Founders Circle Capital | Series C |
| Crawley Ventures | Series A |
| F-Prime Capital | Series B, Series C |
| SpringTime Ventures | Seed |
| Partners Group | Series C |
| Notley | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
Partnered with Definitive Healthcare for target prioritization.
- Mar 30, 2026
Clinicians will use InSync for caseload management and care delivery.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 24, 2026
SonderMind Inc. plans to offer the SonderMind Adjunctive Care Application, a smartphone app that helps reduce anxiety and depression in adults as an adjunct to therapy or medication, in Colorado.
For institutional investors. Book with your work email.
SonderMind Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SonderMind's valuation, stock price, and market status.
Is SonderMind a public or private company?
SonderMind is a private company.
What is the current stock price of SonderMind?
SonderMind is a private company, so its shares have no public market price. Caplight tracks SonderMind's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SonderMind worth (valuation)?
SonderMind's valuation is estimated at $1.1B based on funding round data.
Can I buy SonderMind stock?
SonderMind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SonderMind's last funding round?
SonderMind's most recent funding round was Series C on July 27, 2021.
Who are the main investors in SonderMind?
Key investors in SonderMind include General Catalyst, Kickstart Fund, Dioko Ventures, Premji Invest, Kickstart.
Will SonderMind IPO soon?
No public IPO plans have been announced for SonderMind.
How can I track SonderMind secondary market activity?
Caplight tracks bids, offers, and trades in SonderMind's shares on secondary markets.